Sugi Predict

Sugi Predict / Compounds / SCHEMBL301664

SCHEMBL301664

SCHEMBL301664

CCCCCCCCC1CC1C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.59
▸ GABRR1 P24046 4/20 0.47
▸ GABRR2 P28476 1/20 0.47
▸ ALDH1A1 P00352 5/20 0.44
▸ S1PR3 Q99500 2/20 0.44
▸ TSHR P16473 5/20 0.43
▸ PPARG P37231 6/20 0.40
▸ PPARD Q03181 6/20 0.40
▸ PPARA Q07869 6/20 0.40
▸ HDAC11 Q96DB2 5/20 0.40
▸ GPR84 Q9NQS5 4/20 0.40
▸ TDP1 Q9NUW8 3/20 0.40
▸ TLR2 O60603 2/20 0.40
▸ FABP4 P15090 2/20 0.40
▸ PTPN1 P18031 2/20 0.40
▸ SLC22A6 Q4U2R8 1/20 0.40
▸ SLC22A8 Q8TCC7 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ ESR1 P03372 1/20 0.40
▸ ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10884586 1.00 ALOX5 (0.59) ALOX5GABRR1GABRR2ALDH1A1S1PR3
SCHEMBL17779535 1.00 ALOX5 (0.59) ALOX5GABRR1GABRR2ALDH1A1S1PR3
SCHEMBL417928 1.00 ALOX5 (0.59) ALOX5GABRR1GABRR2ALDH1A1S1PR3
SCHEMBL3491458 1.00 ALOX5 (0.59) ALOX5GABRR1GABRR2ALDH1A1S1PR3
SCHEMBL11213402 1.00 ALOX5 (0.59) ALOX5GABRR1GABRR2ALDH1A1S1PR3
SCHEMBL11414522 1.00 ALOX5 (0.59) ALOX5GABRR1GABRR2ALDH1A1S1PR3
SCHEMBL24354392 1.00 ALOX5 (0.59) ALOX5GABRR1GABRR2ALDH1A1S1PR3
SCHEMBL17779527 1.00 ALOX5 (0.59) ALOX5GABRR1GABRR2ALDH1A1S1PR3
SCHEMBL21972780 1.00 ALOX5 (0.59) ALOX5GABRR1GABRR2ALDH1A1S1PR3
SCHEMBL416169 1.00 ALOX5 (0.59) ALOX5GABRR1GABRR2ALDH1A1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117062798-A Incense odorant 弗门尼舍有限公司 2023-11-14 — — CN claimed
WO-2022207448-A1 INCENSE ODORANT FIRMENICH SA (CH) 2022-10-06 — — WO claimed
US-11236287-B2 2-octylcyclopropyl-1-carboxylic acid and the isomers thereof, and uses of same Albert Vielle (FR) 2022-02-01 — — US claimed
CN-107207401-B 2-octyl cyclopropyl-1-carboxylic acid and isomer and application thereof 阿尔贝维埃耶公司 2021-05-18 — — CN claimed
EP-3221290-B1 2-OCTYLCYCLOPROPYL-1-CARBOXYLIC ACID AND THE ISOMERS THEREOF, AND USES OF SAME ALBERT VIEILLE (FR) 2019-07-17 — — EP claimed
US-20180163157-A1 2-OCTYLCYCLOPROPYL-1-CARBOXYLIC ACID AND THE ISOMERS THEREOF, AND USES OF SAME VIEILLE, ALBERT (FR) 2018-06-14 — — US claimed
US-4201785-A ANTICHOLESTEROL AGENTS SANDOZ INC. (US) 1980-05-06 — — US claimed
EP-4281433-A1 INCENSE ODORANT Firmenich SA (CH) 2023-11-29 — — EP disclosed
CN-117062798-A Incense odorant 弗门尼舍有限公司 2023-11-14 — — CN disclosed
WO-2022207448-A1 INCENSE ODORANT FIRMENICH SA (CH) 2022-10-06 — — WO disclosed
US-11236287-B2 2-octylcyclopropyl-1-carboxylic acid and the isomers thereof, and uses of same Albert Vielle (FR) 2022-02-01 — — US disclosed
US-11236287-B2 2-octylcyclopropyl-1-carboxylic acid and the isomers thereof, and uses of same Albert Vielle (FR) 2022-02-01 — — US disclosed
US-11236287-B2 2-octylcyclopropyl-1-carboxylic acid and the isomers thereof, and uses of same Albert Vielle (FR) 2022-02-01 — — US disclosed
US-20130158272-A1 METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE BY MEANS OF COUPLING METHOD USING PALLADIUM COMPOUND TEIJIN PHARMA LIMITED (JP) 2013-06-20 — — US disclosed
EP-2404908-A1 PROCESS FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE THROUGH COUPLING USING TRANSITION METAL CATALYST Teijin Pharma Limited (JP) 2012-01-11 — — EP disclosed
US-20110313169-A1 PROCESS FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE THROUGH COUPLING USING TRANSITION METAL CATALYST TEIJIN PHARMA LIMITED (JP) 2011-12-22 — — US disclosed
US-4762949-A Acyl and carbamimidoyl alkanediamines UNIVERSITY OF ILLINOIS FOUNDATION (US) 1988-08-09 — — US disclosed
EP-0015604-B1 COMPOUNDS AND COMPOSITIONS FOR USE IN INHIBITION OF LIPOGENESIS IN MAMMALS SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1983-02-23 — — EP disclosed
EP-0015604-A1 Compounds and compositions for use in inhibition of lipogenesis in mammals SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1980-09-17 — — EP disclosed
US-4202902-A VETERINARY MEDICINE SHELL OIL COMPANY (US) 1980-05-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180163157-A1 2-OCTYLCYCLOPROPYL-1-CARBOXYLIC ACID AND THE ISOMERS THEREOF, AND USES OF SAME PCCA, MTHFD2, OTC ALOX5 234/4885GABRR1 1665/4885GABRR2 1654/4885
US-20110313169-A1 PROCESS FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE THROUGH COUPLING USING TRANSITION METAL CATALYST XDH, PAH, HPRT1 ALOX5 880/4885GABRR1 4437/4885GABRR2 4482/4885
US-11236287-B2 2-octylcyclopropyl-1-carboxylic acid and the isomers thereof, and uses of same PCCA, MTHFD2, OTC ALOX5 234/4885GABRR1 1665/4885GABRR2 1654/4885
US-20130158272-A1 METHOD FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE BY MEANS OF COUPLING METHOD USING PALLADIUM COMPOUND XDH, AOC1, PAH ALOX5 565/4885GABRR1 3535/4885GABRR2 3761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.